The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients

OBJECTIVES: The recent conflicting data on the mortality benefit of neuromuscular blocking agents in acute respiratory distress syndrome and the potential adverse effects of continuous neuromuscular blocking agent necessitates that these medications should be used judiciously with dose reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadique, Sarah, Badami, Varun, Forte, Michael, Kovacic, Nicole, Umer, Amna, Shigle, Amanda, Gardo, Jordan, Sangani, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994065/
https://www.ncbi.nlm.nih.gov/pubmed/33786447
http://dx.doi.org/10.1097/CCE.0000000000000371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994065/
https://www.ncbi.nlm.nih.gov/pubmed/33786447
http://dx.doi.org/10.1097/CCE.0000000000000371

Ejemplares similares